Faculty, Staff and Student Publications
Language
English
Publication Date
1-1-2023
Journal
Frontiers in Pharmacology
DOI
10.3389/fphar.2023.1169812
PMID
37197407
PMCID
PMC10184183
PubMedCentral® Posted Date
April 2023
PubMedCentral® Full Text Version
Post-print
Abstract
There is no first-line treatment for vitiligo, a skin disease characterized by a lack of melanin produced by the melanocytes, resulting in an urgent demand for new therapeutic drugs capable of stimulating melanocyte functions, including melanogenesis. In this study, traditional medicinal plant extracts were tested for cultured human melanocyte proliferation, migration, and melanogenesis using MTT, scratch wound-healing assays, transmission electron microscopy, immunofluorescence staining, and Western blot technology. Of the methanolic extracts, Lycium shawii L. (L. shawii) extract increased melanocyte proliferation at low concentrations and modulated melanocyte migration. At the lowest tested concentration (i.e., 7.8 μg/mL), the L. shawii methanolic extract promoted melanosome formation, maturation, and enhanced melanin production, which was associated with the upregulation of microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein (TRP)-1 and TRP-2 melanogenesis-related proteins, and melanogenesis-related proteins. After the chemical analysis and L. shawii extract-derived metabolite identification, the in silico studies revealed the molecular interactions between Metabolite 5, identified as apigenin (4,5,6-trihydroxyflavone), and the copper active site of tyrosinase, predicting enhanced tyrosinase activity and subsequent melanin formation. In conclusion, L. shawii methanolic extract stimulates melanocyte functions, including melanin production, and its derivative Metabolite 5 enhances tyrosinase activity, suggesting further investigation of the L. shawii extract-derived Metabolite 5 as a potential natural drug for vitiligo treatment.
Keywords
Lycium shawii, human melanocyte, melanogenesis, melanin, natural product, skin depigmentation, vitiligo
Published Open-Access
yes
Recommended Citation
Alghamdi, Khalid; Alehaideb, Zeyad; Kumar, Ashok; et al., "Storage Stability of Atheroglitatide, an Echogenic Liposomal Formulation of Pioglitazone Targeted to Advanced Atheroma with a Fibrin-Binding Peptide" (2023). Faculty, Staff and Student Publications. 2485.
https://digitalcommons.library.tmc.edu/uthmed_docs/2485
Included in
Dermatology Commons, Medical Pathology Commons, Medical Pharmacology Commons, Skin and Connective Tissue Diseases Commons